Quick Takeaways
- GENMAB A/S filed SCHEDULE 13D/A for Merus N.V. Common Shares, Euro 0.09 nominal value per share (MRUS).
- Disclosed ownership: 0%.
- Date of event: 30 Dec 2025.
GENMAB A/S - 30 Dec 2025 SCHEDULE 13D/A Report for Merus N.V. Common Shares, Euro 0.09 nominal value per share (MRUS)
- Filing Manager
- GENMAB A/S
- Reporting Manager
- Genmab A/S
- Symbol
- MRUS
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13D/A
- Filing time
- 30 Dec 2025, 17:24:40 UTC
- Date of event
- 30 Dec 2025
- Previous filing
- 19 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"GENMAB A/S disclosed 0% ownership in Merus N.V. Common Shares, Euro 0.09 nominal value per share (MRUS) on 30 Dec 2025."
What Changed
- Previous schedule filing date: 19 Dec 2025.
- Current filing was accepted on 30 Dec 2025, 17:24.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Genmab A/S | 0% | 0 | 0 | 0 | /s/ Jan G. J. van de Winkel | Jan G. J. van de Winkel, President & Chief Executive Officer | 0001434265 |
| Genmab Holding II B.V. | 0% | 0 | 0 | 0 | /s/ Jan G. J. van de Winkel | Jan G. J. van de Winkel, Authorized Signatory |